| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
6,643 | 9,736 | 14,450 | 33,868 | 24,473 |
| Cost of Revenue
|
-7,489 | -9,707 | -13,460 | -19,768 | -16,216 |
|
Gross Profit
|
-847 | 28 | 990 | 14,100 | 8,257 |
| Selling, General and Administrative Expenses
|
-6,845 | -6,073 | -8,980 | -10,531 | -14,337 |
|
Operation and Maintenance Expenses
|
-309 | -309 | -586 | -539 | -646 |
|
Research and Development Expenses
|
-2,815 | -1,081 | -2,018 | -1,438 | -1,127 |
| Depreciation, Amortization and Depletion
|
-2,342 | -2,342 | -2,971 | -3,240 | -3,005 |
|
Taxes Other Than Income Taxes
|
-- | -- | -- | -24 | -47 |
| Provision Expense/Write-Back
|
-1,470 | -1,470 | 0 | 0 | -- |
|
Operating Income/Expenses
|
-11,208 | -11,275 | -14,555 | -15,748 | -19,115 |
|
Total Operating Profit/Loss
|
-12,055 | -11,247 | -13,565 | -1,648 | -10,858 |
| Total Net Finance Income/Expense
|
-199 | -138 | -152 | -219 | -171 |
| Net Investment Income
|
-286 | -286 | 102 | 424 | -960 |
| Irregular Income/Expenses
|
-11,380 | -11,380 | -9,365 | 28 | -1,102 |
|
Other Income/Expense, Non-Operating
|
0 | -- | 0 | 0 | 1,101 |
|
Non-Operating Income/Expenses, Total
|
-11,865 | -11,804 | -9,415 | 233 | -1,132 |
|
Pretax Income
|
-23,920 | -23,051 | -22,980 | -1,415 | -11,990 |
|
Provision for Income Tax
|
1,306 | 1,443 | 182 | 870 | 1,093 |
|
Net Income from Continuing Operations
|
-22,614 | -21,608 | -22,798 | -545 | -10,897 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-22,614 | -21,608 | -22,798 | -545 | -10,897 |
|
Net Income after Non-Controlling/Minority Interests
|
-22,614 | -21,608 | -22,798 | -545 | -10,897 |
|
Net Income Available to Common Stockholders
|
-22,614 | -21,608 | -22,798 | -545 | -10,897 |
|
Diluted Net Income Available to Common Stockholders
|
-22,614 | -21,608 | -22,798 | -545 | -10,897 |
| Basic EPS
|
-0.37 | -0.22 | -0.25 | -0.01 | -0.14 |
| Diluted EPS
|
-0.37 | -0.22 | -0.25 | -0.01 | -0.14 |
|
Basic Weighted Average Shares Outstanding
|
131,474.31 | 95,462 | 91,965 | 80,170 | 80,170 |
|
Diluted Weighted Average Shares Outstanding
|
131,474.31 | 95,462 | 91,965 | 80,170 | 80,170 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-23,721 | -22,913 | -22,828 | -1,196 | -11,819 |
|
EBITDA
|
-23,721 | -19,477 | -18,515 | 2,961 | -7,721 |
12/31/2022 - 2/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade